Pfizer CEO Albert Bourla said it will deliver Seagen’s cancer therapy to the world at a scale that hasn’t been seen before with its $43 billion acquisition.
Radioligand therapy is a ‘game -hanger’ for cancer treatment, but it forces manufacturers to race against a ticking clock.
){kind=link}
){kind=link}
){kind=link}